Arrhythmogenic right ventricular cardiomyopathy resident survival guide
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Steven Bellm, M.D. [2]
| Arrhythmogenic right ventricular cardiomyopathy resident survival guide Microchapters |
|---|
| Overview |
| Classification |
| Causes |
| FIRE |
| Diagnosis |
| Treatment |
| Do's |
| Dont's |
Overview
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disease characterized by myocyte loss and fibro-fatty tissue replacement of the right ventricular myocardium. This puts patients into risk of life-threatening ventricular arrhythmias and slowly progressive ventricular dysfunction. The diagnostic is challenging. Diagnosis of ARVC relays on a scoring system, with major or minor criteria on the Revised Task Force Criteria. Pharmacologic treatment of arrhythmias, catheter ablation of ventricular tachycardia, and ICD are main goals of the treatment.[1]
Classification
Causes
Life Threatening Causes
Common Causes
FIRE: Focused Initial Rapid Evaluation
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
| A01 | |||||||||||||||||||||||||||||||||
| B01 | B02 | ||||||||||||||||||||||||||||||||
| C01 | |||||||||||||||||||||||||||||||||
| D01 | D02 | D03 | |||||||||||||||||||||||||||||||
| E01 | E02 | E03 | |||||||||||||||||||||||||||||||
| F01 | F02 | ||||||||||||||||||||||||||||||||
Complete Diagnostic Approach
| A01 | |||||||||||||||||||||||||||||||||
| B01 | B02 | ||||||||||||||||||||||||||||||||
| C01 | |||||||||||||||||||||||||||||||||
| D01 | D02 | D03 | |||||||||||||||||||||||||||||||
| E01 | E02 | E03 | |||||||||||||||||||||||||||||||
| F01 | F02 | ||||||||||||||||||||||||||||||||
Treatment
shown
hidden
Do's
Dont's
References
- ↑ Pinamonti B, Brun F, Mestroni L, Sinagra G (2014). "Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges". World J Cardiol. 6 (12): 1234–44. doi:10.4330/wjc.v6.i12.1234. PMC 4278158. PMID 25548613.